Brief: Alteogen Signs Licensing Deal With Biogen International For Alt-B4
25/03/2026 07:57
Alteogen Inc 196170.KQ: SIGNS LICENSING DEAL WITH BIOGEN INTERNATIONAL FOR ALT-B4 DEAL WITH BIOGEN CAN GENERATE UP TO $549 MILLION MILESTONES Source text: [ID:] Further company coverage: 196170.KQ
Recent news on Alteogen
See all newsDeals of the day-Mergers and acquisitions
Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology
Brief: Alteogen To Invest 253 Billion Won In Construction Of New Factory
Brief: Alteogen Q2 Operating. Profit 34.2 Billion Won
Brief: Alteogen - Signs Exclusive License Agreement For Alt-B4 Recombinant Human Hyaluronidase